Concierge MedTravel logo for Medical Travel for prostate cancer and prostate cancer treatment and diagnosis
English French German Italian Spanish

Click a flag to convert to a different language

Concierge MedTravel Image of an older couple – Medical Travel

Prostate Cancer Diagnosis

Prostate cancer diagnosis image as it relates to prostate cancer treatments

The American Cancer Society recommends that starting at the age of 50, men at average risk should have a blood test to record levels of prostate specific antigen (PSA) and the digital rectal examination to feel for any abnormalities such as hardness or increased size.  Men at high risk of developing prostate cancer (a family history or African Americans) should begin screening at age 45.

An elevated PSA score from 4 to 10 ng/ml suggests the presence of prostate cancer.  The diagnosis of prostate cancer is usually confirmed by a biopsy, MRI and/or CT scan.

Once a definite diagnosis of cancer has been made the next step is to know what the cancer's stage is.  Cancer staging helps determine which treatment will work the best.

Prostate Cancer Classification:

  • Stage T1Early stage cancer confined to the prostate (T-1)
  • Stage T2 - Cancer is bigger and makes prostate harder; Confined to the prostate (T-2)
  • Stage T3 - Locally advanced cancer extending beyond the prostate (T-3) 
  • Stage T4 - Cancer has spread to other organs such as lymph nodes or bones (T-4) 

 

DISCLAIMER: This information is provided for informational purposes only.  Ablatherm ® HIFU is a non-FDA approved treatment that is in clinical trials in the U.S.  Ablatherm HIFU has been approved by and is being performed in certain countries other than the U.S.  For answers to your medical questions, you should consult your urologist.